Physician profile
Lise Phan
NPI 1487031100
$10,419.90
in general payments reported to CMS, 2019-2025
59 companies · $2,415 in 2025
The $2,415 reported for 2025 was more than what 75% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $580 · 2020: $40.74 · 2021: $477 · 2022: $1,426 · 2023: $2,553 · 2024: $2,927 · 2025: $2,415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,685 · Education: $204 · Travel and Lodging: $6.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,685.46 |
| Education | $203.53 |
| Travel and Lodging | $6.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,254.97 | 2021-2025 | |
| Biogen, INC. | $1,072.30 | 2019-2025 | Vumerity, Tysabri, Spinraza |
| Ucb, INC. | $1,018.79 | 2023-2025 | Rystiggo, Zilbrysq, Fintepla |
| Novartis Pharmaceuticals Corporation | $781.43 | 2022-2025 | |
| Acadia Pharmaceuticals INC | $779.37 | 2022-2025 | Nuplazid |
| Alexion Pharmaceuticals, INC. | $707.60 | 2022-2025 | Ultomiris |
| Eisai INC. | $452.23 | 2022-2025 | |
| Amneal Pharmaceuticals LLC | $427.12 | 2022-2025 | Crexont, Rytary |
| Lilly USA, LLC | $269.94 | 2022-2025 | Kisunla, Emgality, Reyvow |
| Shire North American Group INC | $244.84 | 2019 | |
| Lundbeck LLC | $220.18 | 2021-2025 | Vyepti |
| Celgene Corporation | $199.50 | 2022-2025 | Zeposia |
| Amgen INC. | $195.77 | 2022-2025 | Uplizna, Aimovig |
| Pfizer INC. | $173.00 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $163.98 | 2022-2025 | Austedo Xr, Austedo Xr |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lise Phan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.